Impacto de los cambios en la prescripción del tratamiento anticoagulante en laincidencia de ictus

Q4 Medicine
Roman Freixa-Pamias , Alejandro Isidoro Pérez Cabeza , Alfonso Valle Muñoz , Ignacio Fernández Lozano
{"title":"Impacto de los cambios en la prescripción del tratamiento anticoagulante en laincidencia de ictus","authors":"Roman Freixa-Pamias ,&nbsp;Alejandro Isidoro Pérez Cabeza ,&nbsp;Alfonso Valle Muñoz ,&nbsp;Ignacio Fernández Lozano","doi":"10.1016/S1131-3587(21)00003-0","DOIUrl":null,"url":null,"abstract":"<div><p>Atrial fibrillation markedly increases the risk of stroke. Numerous clinical trials and real-life studies have demonstrated that anticoagulant treatment decreases the risk of thromboembolic complications. For anticoagulation, direct oral anticoagulants (DOACs) have a better efficacy and safety profile than vitamin K antagonists. Studies performed in countries neighboring Spain in recent years have identified reductions in the incidence of ischemic stroke that could be related to increased prescripción of oral anticoagulants, particularly DOACs. In Spain itself, información about this issue is very scarce. Nevertheless, the data available indicate that, here too, increased prescripción of oral anticoagulants, particularly DOACs, has also been associated with a significant decrease in the incidence of both ischemic stroke and intracranial hemorrhage. Therefore, it is recommended that DOACs be used more frequently in patients with atrial fibrillation, as this would contribute to reducing not only the incidence of ischemic stroke and intracranial hemorrhage but also the associated economic burden.</p></div>","PeriodicalId":34926,"journal":{"name":"Revista Espanola de Cardiologia Suplementos","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Espanola de Cardiologia Suplementos","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1131358721000030","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Atrial fibrillation markedly increases the risk of stroke. Numerous clinical trials and real-life studies have demonstrated that anticoagulant treatment decreases the risk of thromboembolic complications. For anticoagulation, direct oral anticoagulants (DOACs) have a better efficacy and safety profile than vitamin K antagonists. Studies performed in countries neighboring Spain in recent years have identified reductions in the incidence of ischemic stroke that could be related to increased prescripción of oral anticoagulants, particularly DOACs. In Spain itself, información about this issue is very scarce. Nevertheless, the data available indicate that, here too, increased prescripción of oral anticoagulants, particularly DOACs, has also been associated with a significant decrease in the incidence of both ischemic stroke and intracranial hemorrhage. Therefore, it is recommended that DOACs be used more frequently in patients with atrial fibrillation, as this would contribute to reducing not only the incidence of ischemic stroke and intracranial hemorrhage but also the associated economic burden.

抗凝治疗处方变化对中风发生率的影响
房颤明显增加中风的风险。大量临床试验和现实生活研究表明,抗凝治疗可降低血栓栓塞并发症的风险。在抗凝方面,直接口服抗凝剂(DOACs)比维生素K拮抗剂具有更好的疗效和安全性。近年来在西班牙邻国进行的研究发现,缺血性卒中发病率的降低可能与口服抗凝剂prescripción的增加有关,特别是doac。在西班牙国内,关于这个问题的información很少。然而,现有的数据表明,口服抗凝剂prescripción的增加,特别是DOACs,也与缺血性卒中和颅内出血发生率的显著降低有关。因此,建议在房颤患者中更频繁地使用doac,因为这不仅有助于减少缺血性卒中和颅内出血的发生率,而且还有助于减少相关的经济负担。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Revista Espanola de Cardiologia Suplementos
Revista Espanola de Cardiologia Suplementos Medicine-Cardiology and Cardiovascular Medicine
CiteScore
1.20
自引率
0.00%
发文量
1
期刊介绍: Revista Española de Cardiología, is an international scientific journal dealing with cardiovascular medicine. Revista Española de Cardiología, the official publication of the Spanish Society of Cardiology, publishes research articles related to cardiovascular diseases. Articles are published in Spanish for the paper edition and in both Spanish and English in the electronic edition, which is available on the Internet. Regular sections include original articles reporting clinical or basic research, brief reports, review articles, editorials and letters to the Editor.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信